Close Menu

NEW YORK (GenomeWeb) – OraSure Technologies announced today that it has agreed to acquire early-stage microbiome services provider CoreBiome and urine sample collection device developer Novosanis.

The transactions are structured with an upfront payment and potential additional payments based on future performance. Additional financial terms were not disclosed. The deals are expected to close within the next week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.